Cadherin-17: A potential biomarker for early detection in pancreatic adenocarcinoma

Figure 1 Cadherin 17 expression in pancreatic tissue samples and its association with clinicopathological features. A: Cadherin 17 (CDH17) M-scores in healthy pancreatic tissues (n = 22), paired normal adjacent tissues (n = 25) and pancreatic tumor tissues (n = 25). Data are presented as box-and-whisker plots showing the median, interquartile range, and range. Relationships between CDH17 M-scores and clinicopathological variables; B: Sex; C: Age; D: Tumor site; E: Differentiation grade; F: Disease stage (stages I/II vs III/IV); G: Relapse status (relapse < 1 year vs ≥ 1 year); H: Prognosis (overall survival ≥ 3 years vs < 3 years). None of the factors examined showed significant associations.